银屑病疾病模型
Fig1. In vivo efficacy evaluation of anti-IL23 and anti-IL23/IL12 in imiquimod (IMQ)-induced psoriasis model in hIL23A/hIL12B mice (3-6 mice/group, 6
Fig.1 Body weight and body weight change among time during study. Body weight and body weight change in anti-IL23 treated imiquimod (IMQ)-induced psor
